Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DANAPAROID for Thrombocytopenia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where DANAPAROID was used for Thrombocytopenia.

Most Reported Side Effects for DANAPAROID

Side Effect Reports % Deaths Hosp.
Heparin-induced thrombocytopenia 27 15.9% 8 19
Acute kidney injury 14 8.2% 11 3
Shock haemorrhagic 14 8.2% 11 2
Haematoma 12 7.1% 9 4
Thrombocytopenia 12 7.1% 3 5
Off label use 11 6.5% 2 8
Deep vein thrombosis 10 5.9% 2 7
International normalised ratio increased 10 5.9% 7 3
Anaemia 9 5.3% 0 8
Haemorrhage 9 5.3% 5 0
Maternal exposure during pregnancy 9 5.3% 0 0
Rectal haemorrhage 9 5.3% 1 8
Cerebral haemorrhage 8 4.7% 8 2
Stevens-johnson syndrome 8 4.7% 8 0
Condition aggravated 7 4.1% 1 6

Other Indications for DANAPAROID

Product used for unknown indication (50) Heparin-induced thrombocytopenia (34) Thrombosis prophylaxis (22) Anticoagulant therapy (18) Pulmonary embolism (15)

Other Drugs Used for Thrombocytopenia

ELTROMBOPAG OLAMINE (1,315) ROMIPLOSTIM (586) ELTROMBOPAG (531) FOSTAMATINIB (483) AVATROMBOPAG (340) HUMAN IMMUNOGLOBULIN G (245) RITUXIMAB (243) RUXOLITINIB (162) PREDNISONE (128) METHYLPREDNISOLONE (103)

Related Pages

DANAPAROID Full Profile All Thrombocytopenia Drugs DANAPAROID Demographics DANAPAROID Timeline